The scrutiny centers on production and construction setbacks that significantly hampered the company’s fiscal performance. On August 5, 2026, Fluence announced that $400 million in expected deliveries would be deferred to fiscal 2027. The market response was immediate, driving the stock price down to $14.23 per share.
The situation worsened on September 16, 2026, when the company issued another sharp reduction in its outlook. Citing persistent delays at its Houston manufacturing facility, the firm lowered its fiscal 2026 revenue expectations to approximately $2.4 billion and projected an adjusted EBITDA loss of $200 million. Shares subsequently fell to $7.66 per share by the close of trading on September 17. Investors who held stock during these periods are encouraged to contact Danielle Peyton at Pomerantz LLP to discuss potential participation in class action litigation.
Comments (0)
No comments yet. Be the first!